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Purpose: To develop a deep learning approach to digitally segmenting meibomian
gland atrophy area and computing percent atrophy in meibography images.
Methods: A total of 706 meibography images with corresponding meiboscores were
collected and annotated for each one with eyelid and atrophy regions. The dataset
was then divided into the development and evaluation sets. The development set was
used to train and tune the deep learning model, while the evaluation set was used to
evaluate the performance of the model.
Results: Four hundred ninety-seven meibography images were used for training and
tuning the deep learning model while the remaining 209 images were used for
evaluations. The algorithm achieves 95.6% meiboscore grading accuracy on average,
largely outperforming the lead clinical investigator (LCI) by 16.0% and the clinical
team by 40.6%. Our algorithm also achieves 97.6% and 95.4% accuracy for eyelid and
atrophy segmentations, respectively, as well as 95.5% and 66.7% mean intersection
over union accuracies (mean IU), respectively. The average root-mean-square
deviation (RMSD) of the percent atrophy prediction is 6.7%.
Conclusions: The proposed deep learning approach can automatically segment the
total eyelid and meibomian gland atrophy regions, as well as compute percent
atrophy with high accuracy and consistency. This provides quantitative information of
the gland atrophy severity based on meibography images.
Translational Relevance: Based on deep neural networks, the study presents an
accurate and consistent gland atrophy evaluation method for meibography images,
and may contribute to improved understanding of meibomian gland dysfunction.
Introduction
Dry eye disease is a multifactorial ocular surface
disorder and is very common among adults. Meibo-
mian glands (MGs) are believed to play a critical role
in ocular surface health by secreting lipids into the
tear film to slow down the rate of aqueous
evaporation and minimize symptoms of dry eye.
Dysfunction of MGs is the most frequent cause of dry
eyes.1 The ability to visualize the glands and to
monitor their changes with time or treatment is
important for evaluating the risk of meibomian gland
dysfunction (MGD) and dry eye diseases. Meibog-
raphy, which is a photo documentation of MGs in the
eyelids using either transillumination or infrared light,
is commonly used in dry eye clinics for the diagnosis,
treatment, and management of MGD.
The measurement of glandular loss is of significant
clinical impact for the diagnosis of MGD.2,3 Percent
MG atrophy, the ratio of gland loss area to the total
eyelid area, may be an important clinical factor for
assessing MGD severity. Using a standardized MG
atrophy grading scale, the percent atrophy can be
classified based on severity.4,5 In this paper, a
previously published clinical-grading system6 (i.e.,
meiboscore) was applied (Table 1). Figure 1 depicts
some sample meibography images with varying
percent atrophy and corresponding meiboscores to
help readers gain insights on the relationship between
the percent atrophy and meiboscore. Currently,
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clinicians subjectively estimate the degree of MG
atrophy severity. They assign a severity score after
grossly estimating the relative ratio between MG
atrophy area and total eyelid area. This subjective
assessment has several limitations: (1) it may have
high inter- and intraobserver variability and low
repeatability7,8; (2) it is based on qualitative judg-
ments, therefore lacking quantitative evaluations to
accurately track longitudinal changes; and (3) it may
take a longer time and more costs to manually process
a large number of images.
Recent advances in deep learning,9–11 a particular
form of artificial intelligence (AI), show the ability of
deep neural networks to learn predictive features
directly from a large dataset of labeled images, without
explicitly specifying rules or features. Additionally,
deep learning has shown great success in medical
imaging, such as diabetic retinopathy,12–14 breast
cancer,15,16 melanoma,17 and others.18,19 It is of interest
to use deep learning methods to benefit the process of
evaluating atrophy in meibography images. Specifical-
ly, clinicians can use such methods to automatically
segment the eyelid and atrophy areas in meibography
images, and then compute the percent atrophy, for the
purpose of evaluating MG atrophy. Therefore, an
automated method will potentially provide valuable
and timely information on MG atrophy.
This study aimed primarily to develop and validate
an automated deep learning system for evaluating
MG atrophy severity from meibography images with
clinician-verified annotations of eyelid and atrophy
areas. Additionally, the performance of human
clinicians and deep learning algorithm in determining
the atrophy severity in meibography images were
compared.
Methods
Development and Evaluation Dataset
This study was based on the utilization of a
meibography image dataset with clinician-verified
annotations of eyelid and atrophy areas, for deep
learning algorithm development and evaluation.
Subject Recruitment and Demographics
Adult human subjects (ages 18 years) were
recruited from the University of California, Berkeley
(UCB) campus and surrounding community for a
single-visit ocular surface evaluation during the
period from 2012 to 2017. During the visits,
meibography images of the upper and lower eyelids
for both eyes were captured with the OCULUS
Keratograph 5M (OCULUS, Arlington, WA), a
clinical instrument that uses an infrared light with
wavelength 880 nm for MG imaging.20 During image
captures, the same testing conditions were kept (i.e.,
the ambient light was off with the subject’s head
positioned on the chin rest and forehead strap). Yeh
and Lin21 showed that MG contrast in meibography
captured using the same instrument was repeatable
and invariant to ambient light conditions and head
poses. Only upper eyelid images were used in this
study. A total of 775 images were collected and
prescreened to rule out images that did not capture
the entire upper eyelid (69 images or 8.90%).
Examining clinicians assigned an MG atrophy sever-
ity score during the exam using the meiboscore scale
in Table 1, which was previously defined.6 The
meiboscores assigned during the examination were
referred to as ‘‘clinical meiboscore’’ and were assigned
Table 1. Percent MG Atrophy to Meiboscore
Conversion Criteria6
MG Atrophy, % Meiboscore
0 0
0–33 1
33–66 2
.66 3
Figure 1. Meibography images with ground-truth percent
atrophies (%) and ground-truth meiboscores. Rows 1 to 4 refer
to images with meiboscores of grade 0 to 3, respectively. Given a
meibography image, the area of gland atrophy (marked in red) and
eyelid (marked in blue) are compared by our deep learning
algorithm to estimate the percent atrophy A (Equation 1), and are
further converted to meiboscore according to the criteria in Table
1.
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by multiple clinicians. All clinicians were masked
from the subject’s ocular surface health status. The
most experienced clinician (TNY) also provided a
separate set of the clinical meiboscore data for
evaluation purposes (i.e., comparing scores among
group clinicians, the lead clinical investigator [LCI]
and our machine-learning algorithm against the
ground-truth data generated by the machine algo-
rithms). Subject demographics can be found in Table
2.
Data Annotations
A team of trained individuals labeled and mea-
sured the total eyelid and atrophy regions using the
polygon tool in Fiji (ImageJ version 2.0.0-rc-59;
Bethesda, MD).22 For labeling the total eyelid region,
the upper border was defined at the MG orifices, the
lower border was set at the edge of proximal tarsal
plate, and the horizontal borders were where the top
and bottom borders intersected. For labeling the total
atrophy region, the upper border was drawn at the
proximal ends of normal glands, the lower border was
at the edge of proximal tarsal plate, and the
horizontal borders were where the upper and lower
borders intersected. Portions of glands that appeared
atrophied (e.g., fainter, thinner) compared with other
glands on the same eyelid were included in the
atrophy region. The areas measured for the regions
of interest were captured by selecting ‘‘Ana-
lyze.Measure’’ when the regions of interest were
active. Final annotations were verified by an LCI
(TNY) before they were made available for the
machine-learning algorithm to minimize variability
in the ground-truth data. From the fine-grained MG
atrophy and total eyelid area annotation masks, these
ground-truth annotated data were used to calculate
the percent atrophy, which was then converted to
meiboscore according to Table 1, for generating both
‘‘ground-truth percent atrophy’’ and the ‘‘ground-
truth meiboscore.’’ Figure 1 depicts examples of
atrophy- and eyelid-area annotations, along with
corresponding ground-truth percent atrophy and
ground-truth meiboscores. Algorithms were consid-
ered to achieve 100% accuracy if they predicted results
exactly the same as the ground-truth annotations.
Note that machine-learning systems can ‘‘predict’’ the
MG atrophy region and percent atrophy from an
meibography image not seen in the training phase.
Machine predictions are different from medical
predictions, which usually refer to predicting the
future status of a disease or condition.
Data Allocations
All meibography images were randomly allocated
into the following two sub-datasets: development and
evaluation. The former was used for developing the
deep learning algorithm, while the latter was for
evaluating the performance of the algorithm. The
percent atrophy distributions of the two datasets were
very similar as shown in Figure 2. This minimized the
scenario differences between training and evaluation.
For algorithm development, the development dataset
was further divided randomly into 2 subsets, a train
and validation set. The images in the train set were
used to train the deep learning model, while the
validation set was used for tuning the model hyper-
parameters (e.g., network architectures, learning rate,
etc.). The evaluation dataset, which did not have any
overlapping image with the development dataset, was
evaluated using the model that achieved the best
performance from the validation set. The patient
demographics and atrophy severity of the develop-
Table 2. Subject Demographics and Meiboscores of the Meibography Image Datasets
Development
EvaluationTrain Validation
Images, N 398 99 209
Patient demographics
Unique individuals, N 308 77 191
Age, average 6 SD 25.5 6 10.9 27.0 6 12.6 26.4 6 11.6
Female/total patients, % 63.5 66.6 68.3
Atrophy severity distribution, n (%)
Meiboscore 0 73 (18.3) 18 (18.2) 38 (18.2)
Meiboscore 1 267 (67.1) 67 (67.7) 142 (67.9)
Meiboscore 2 53 (13.3) 13 (13.1) 27 (12.9)
Meiboscore 3 5 (1.3) 1 (1.0) 2 (1.0)
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ment and evaluation datasets can be found in Table 2
and Figure 3.
Algorithm Design and Training
In computer vision, image segmentation is the
process of partitioning an image into multiple
segments.23,24 Earlier methods first extracted hand-
engineered features of the image, and then used the
features to classify pixels independently.25–27 More
recently, deep learning methods incorporated feature
extraction and classification together into a unified
framework, and achieved the state-of-the-art in image
segmentation.11,28 A deep learning algorithm was
built upon the pyramid scene parsing network29 to
segment the atrophy and eyelid region of a given
meibography image, and then the percent atrophy
was calculated (Fig. 4).
The input to the neural network was a meibog-
raphy image. The network could be considered as
several stages of computations, parameterized by
millions of parameters, and mapped the input image
to the output segmentation masks of MG atrophy
and eyelid area. Additionally, the network generated
a vector indicating if MG atrophy existed in a given
meibography image. The auxiliary output helped
improve the segmentation performance by providing
additional information. The final optimization goal
was to have both correct segmentation and atrophy
existence vector prediction.
Parameters of a neural network were determined
by training the network on the development dataset.
The network was repeatedly given images with known
ground truth (the segmentation masks of atrophy and
eyelid area, as well as atrophy existence vectors in our
model). The model predicted the segmentation masks
and atrophy existence vector of the given meibog-
raphy image, and adjusted its parameters over the
training process to make predictions increasingly
more similar to the ground truth. The parameters of
the model were optimized using stochastic gradient
descent30 and the model performance was evaluated
by the validation set every epoch. When atrophy area
and eyelid area were predicted, the percent atrophy A
can be calculated as follows:
A ¼ area of atrophy
area of eyelid
ð1Þ
A hyperparameter search was performed on the
network architectures, data-augmentation techniques,
learning rate, auxiliary loss ratio, and learning-rate
decreasing policy. The hyperparameters, which at-
tained the best performance over the validation set,
was selected. The convolutional neural networks were
developed using the PyTorch31 deep learning frame-
work. The proposed networks were repeatedly trained
and evaluated on two NVIDIA GeForce GTX 1080
GPUs with NVIDIA CUDA v8.0 and NVIDIA
Figure 3. Data composition by atrophy severity. The meiboscore
distributions of the train, validation, and evaluation sets are similar,
indicating the scenario differences among training, validation, and
evaluation are minimized.
Figure 4. The pipeline to evaluating meibography atrophy. The
network aims to predict the atrophy area (white part in the right
image) and the total eyelid area (white and gray part in the right
image). Based on the predicted mask, the percent atrophy can be
calculated.
Figure 2. Percent atrophy distribution of the development and
evaluation datasets. The distributions of the two sets are similar,
indicating the scenario differences between training and
evaluation are minimized.
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cuDNN v5.1 acceleration (NVIDIA, Santa Clara,
CA).
Evaluation Protocol
Evaluating the performance of the trained deep
model was necessary. First, when performing the
extensive tuning of hyperparameters on the training
set, the model was evaluated on the validation set to
select the hyperparameters that achieved the best
performance. Additionally, once the best-perfor-
mance model was obtained, the performance on the
evaluation set was further evaluated to obtain the
final performance. The algorithmic performance,
including segmentation, percent atrophy, and meibo-
score grading performance, was also examined.
Atrophy Segmentation
Two evaluation metrics were adopted to compre-
hensively assess the similarity between the predicted
MG atrophy region and the ground-truth atrophy
region.
Accuracy (or pixel accuracy). In atrophy segmenta-
tion example, the atrophy region is referred to as our
region of interest (ROI). To evaluate the similarity
between network predictions and the ground truth,
the label of ROI is denoted as class i, while the rest as
class j. In Table 3, nij is denoted as the number of
pixels of class i predicted to belong to class j, nii as the
number of correctly classified ROI pixels (true
positives, TP), nij as the number of pixels wrongly
classified as ROI (false positives, FP), njj as true
negative (TN), and nji as false negative (FN). If the
total pixel of the input image was n, n ¼ nijþniiþ njjþ
nji. Thus, accuracy (abbreviated as ACC) is defined as
follows:
ACC ¼ nii þ njj
n
¼ nii þ njj
nij þ nii þ njj þ nji
¼ TPþ TN
FPþ TPþ TNþ FN ð2Þ
Similarly, in total eyelid area segmentation exam-
ple, the eyelid region would be the ROI. ACC reports
the percentage of pixels in the image that is correctly
classified. However, this metric sometimes provides
misleading results when ROI is small, as the measure
would be biased by mainly reporting how well non-
ROI cases are identified.
Mean IU. Mean intersection over union (mean IU,
or Jaccard index) quantifies the percent overlap
between the target mask and our prediction output.
It measures the number of pixels common between
the target and prediction masks divided by the total
number of pixels present across both masks.
Denoting ground truth ROI segmentation mask as
ground-truth (GT), network predicted segmentation
mask as prediction, mean IU32 could be written as
following:
mean IU ¼ GT \ prediction
GT [ prediction ¼
nii
nij þ nji þ nii
¼ TP
FPþ FNþ TP ð3Þ
Intuitively, Equation 3 is analogous to harmonic
average of the precision and recall, F1-score, which
was defined as 2TPFPþFNþ2TP, and provided a more
‘‘comprehensive’’ evaluation—the method consid-
ered both precision and recall. For segmentation
tasks, higher mean IU value indicated higher
alignment of the algorithm prediction with the
ground-truth.
In summary, ACC reflects the performance of
pixel-wise classification accuracy, while mean IU for
how the predicted ROI segmentation mask overlaps
with the real counterpart. Mean IU is considered as a
stricter evaluation metric than ACC in terms of
segmentation. Both evaluation metrics for each image
in the evaluation dataset and the calculated average
score of all images were reported.
Percent Atrophy
Percent atrophy from the atrophy masks (Equa-
tion 1) can be calculated, and the percent atrophy
performance of algorithm prediction can also be
evaluated against the ground-truth. One standard
way is to compute the atrophy ratio difference over
the evaluation set and compute the root-mean-square
deviation (RMSD) as follows:
Table 3. Confusion Matrix for Illustrating Segmentation Evaluation Metric Mean IU
Class
Ground-Truth
i j
Predicted i nii :True positive # (TP) nij :False positive # (FP)
j nji :False negative # (TN) njj :True negative # (FN)
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RMSD A^
 
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N
XN
i¼1
A^i Ai
 2
vuut ð4Þ
where Ai is the real atrophy ratio of ith image defined
in Equation 1, A^i represent the ith atrophy ratio
predicted by the neural network. N is the total
number of images in evaluation set. Intuitively,
Equation 4 reflects the mean difference between
predicted percent atrophy and ground truth over all
the images in the evaluation set. RMSD could also be
considered as the error made by the algorithm when
predicting the percent atrophy of an image.
Converting to Meiboscores
Percent atrophy, as a numeric indicator, provides
substantial information on the MG atrophy severity
of a meibography image. In order to compare with
human clinicians’ performance, the numeric ratios
were converted back to the meiboscore.
From the meibography images with different
percent atrophy in Figure 1, images near the grading
transition limits (0%, 33%, 66%) were very similar and
difficult to classify. A tolerance threshold near the
grading transition limit was necessary. The converting
criteria in Table 1 was applied with a relaxed
standard. As illustrated in Figure 5, the tolerance
threshold was set at 0.25%, so classifying images with
percent atrophy 0% to 0.25%, 32.75% to 33.25%, and
65.75% to 66.25% either to its ground-truth or
adjacent meiboscores were both considered as correct
prediction. The same relaxed converting criteria for
both human clinicians and algorithm in the experi-
ments were followed for fair comparison.
Results
Network Training Details
Each meibography image and its corresponding
segmentation mask(s) were resized to the size of 420
3 420 pixels. During training, 4003 400 pixels were
randomly cropped out of a given meibography image
and corresponding annotations in every training
epoch for data augmentation. A center crop of 4003
400 pixels was made to a given meibography image
and corresponding annotations during the evaluation
process for both validation and evaluation datasets.
Different network architectures (SqueezeNet, re-
snet18, resnet34, resnet50), auxiliary loss ratio (for 0–
1.0 with grid of 0.1), learning rate, and learning-rate
decreasing policy were carefully assessed to obtain the
best performance of the network on the validation
dataset (the best performance of the network over the
validation set was resnet50, auxiliary loss ratio 0.1,
learning rate 1e-3, 200 epochs in total, with learning
rate decrease at 100, 150, and 180, respectively). The
algorithm performance of the model on the evalua-
tion dataset is reported.
Algorithm Performance
The baseline characteristics of the training and
evaluation dataset were described in Table 2. Devel-
opment and evaluation dataset had similar charac-
teristics regarding patient demographics and MG
atrophy severity.
Table 4 shows the ACC, mean IU, and RMSD of
meibography images with different meiboscores. Note
that images with meiboscore of grade 0 do not have
atrophy so there are no corresponding ACC and
mean IU. The performance of meiboscore of grade 0
can however be measured by RMSD and meiboscore
grading accuracy. Regarding atrophy segmentation,
ACC was higher than mean IU. The instance average
ACC values were 97.6% and 95.5% for eyelid and
atrophy, respectively, while mean IU values were
95.4% and 66.7% for eyelid and atrophy, respectively.
Regarding mean IU for different gland atrophy
severity, mean IU was the lowest for meiboscore of
grade 3 samples, which only included five images in
the training set and only two in evaluation set.
Regarding percent atrophy prediction performance,
the instance average error was 6.7%. Although images
with different meiboscores had relatively similar
RMSD, the RMSD value was the highest at 9.0%
for meiboscore of grade 1 and the lowest at 5.7% for
Figure 5. Relaxed meiboscore conversion rule with the tolerance
threshold. The percent atrophy to the meiboscore conversion
criteria is relaxed with tolerance threshold near the grading
transition limits (0%, 33%, 66%). The threshold is set to be 0.25%.
Therefore, when percent atrophy falls in 0% to 0.25%, 32.75% to
33.25%, or 65.75% to 66.25%, the correct prediction can be either
the ground-truth meiboscore or the adjacent meiboscore.
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meiboscore of grade 2. Although the intention was to
capture each subject for one single visit, there were
three subjects (providing a total of 10 images) from
467 subjects (0.6% subjects) returned to the research
facility for two visits within at least a 2-year time
lapse. Therefore, a 10-fold cross validation was
performed to confirm that the images obtained from
the repeated visits would not bias the study results.
The results (e.g., mean and standard deviation of
ACC, mean IU, and RMSD) were reported in Table
5. Specifically, the development and evaluation sets
were randomly split 10 times according to the number
of images of each meiboscore category presented in
Table 2. The algorithm was trained on different
development sets and evaluated on the corresponding
evaluation sets for 10 times. Figure 6 plots the
predicted percent atrophy versus ground-truth per-
cent atrophy. While most of the points fall on the
ideal line (percent atrophy prediction equals to
ground-truth), the deep learning algorithm tends to
give higher percent atrophy for some cases of meibo-
score of grade 0. This is because the algorithm has
been trained to be sensitive to even small atrophy,
which might have been ignored by clinicians. The
errors are greatly reduced when converting to meibo-
scores using the relaxed criteria as described in the
‘‘evaluation protocols’’ section.
Figure 7 visualizes the atrophy region and eyelid
region segmentation results of clinician team and
computer. From the visualization, the human seg-
mentation and computer segmentation appear to be
very similar, especially for eyelid region segmenta-
tions.
Human Clinician’s Performance
The confusion matrix is a specific table layout that
allows visualizations of how two identities perform
the same classification task. Table 6 shows the
confusion matrices of study clinician and single
clinician. The highest agreement percentage was
69% for meiboscore of grade 1, while the lowest was
40% for meiboscore of grade 3. The kappa score is
0.324 for clinical team and the LCI, which led to a fair
agreement according to Landis et al.33 In other words,
clinicians’ ratings have high variability.
Comparing Meiboscores
The meiboscore grading performance of the
algorithm was compared against the ground-truth
meiboscores. The ground-truth meiboscores were
obtained from the percent atrophy (calculated from
human-annotated segmentation masks) using Table 1.
Tables 7 and Figure 8 show the meiboscore grading
performance by the algorithm, clinical team (clinical
meiboscore), and the LCI meiboscore. The algorithm
Table 5. Performance of the Algorithm Under 10-Fold Cross Validation (%)
Percent Eyelid Area Percent Atrophy Area Percent
Atrophy, RMSDACC Mean IU ACC Mean IU
Meiboscore 0 98.0 6 0.4 96.0 6 0.5 / / 9.8 6 0.8
Meiboscore 1 97.6 6 0.3 95.4 6 0.6 96.1 6 1.7 65.9 6 1.8 5.6 6 0.6
Meiboscore 2 97.9 6 0.5 96.0 6 0.9 94.6 6 1.9 77.3 6 1.8 7.4 6 1.6
Meiboscore 3 92.4 6 2.0 83.8 6 4.0 85.1 6 3.9 61.6 6 4.5 7.3 6 2.0
Class average accuracy 96.4 6 0.8 92.8 6 1.5 91.9 6 2.5 68.3 6 2.7 7.5 6 1.3
Instance average accuracy 97.6 6 0.4 95.5 6 0.7 95.7 6 1.8 67.6 6 1.8 6.6 6 0.8
Table 4. Performance of the Algorithm (%)
Percent Eyelid Area Percent Atrophy Area Percent
Atrophy, RMSDACC Mean IU ACC Mean IU
Meiboscore 0 97.9 96.1 / / 9.0
Meiboscore 1 97.5 95.5 95.7 64.6 6.2
Meiboscore 2 97.6 95.6 94.5 78.3 5.7
Meiboscore 3 91.9 82.1 86.8 63.7 6.9
Class average accuracy 96.3 92.3 92.4 68.8 7.0
Instance average accuracy 97.6 95.5 95.4 66.7 6.7
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achieves 95.6% overall grading accuracy, which
outperforms the LCI meiboscore by 16.0% and
clinical team meiboscore by 40.6%. For each meibo-
score, the algorithm also largely outperforms human
clinicians. Figure 9 depicts some failure cases in
meiboscore grading of human clinicians and our
algorithm. Failure cases appear for both human-
assigned and algorithm meiboscores when percent
atrophy is near the meiboscore grading transition
limits.
Discussion
The present work introduces a deep learning
approach to automatically predict the MG atrophy
region and compute percent atrophy in the meibog-
raphy image. The proposed method has the following
three advantages: (1) low variability and high
repeatability (test–retest reliability); (2) output quan-
titative result rather than qualitative description (e.g.,
specific gland atrophy region and numeric percent
atrophy prediction); and (3) efficient and low cost.
The average processing time per meibography image
was approximately 0.29 seconds (experiments were
performed on one NVIDIA GeForce GTX 1080
GPU). This means that more than 1000 unprocessed
or raw meibography images can be evaluated for
atrophy severity in 5 minutes without additional
human resource needed.
The algorithm also has very high performance.
Accuracies of eyelid area and atrophy area achieve
97.6% and 95.4%, respectively, and the overall mean
IUs are 95.5% and 66.7%, respectively. Our algorithm
achieves a 95.6% overall grading accuracy and
outperforms the LCI meiboscore grading accuracy
by 16%. From the visualization of the predicted eyelid
and atrophy segmentation, the algorithm predictions
have high visual similarity with the ground-truth
annotations.
In all, the proposed algorithm achieves very high
performance with low variability and high repeatabil-
ity in evaluating MG atrophy from meibography
images. Additionally, the proposed algorithm could
Figure 7. Eyelid (outlined in blue) and atrophy (outlined in red) segmentations from the deep learning algorithm versus the ground-
truth. Rows 1 to 4 refer to meiboscores of grade 0 to 3, respectively. The first and third columns are ground-truth images from the
annotators, while the second and fourth columns are algorithm predictions. The algorithm predictions shared high visual similarity with
the ground-truth, especially for eyelid region segmentation.
Figure 6. Algorithm-predicted percent atrophy versus ground-
truth percent atrophy. The average RMSD of the predicted percent
atrophy is 6.7%. While most of the points fall on the ideal line
(percent atrophy prediction equals to the ground-truth), more
percent atrophy errors occurred for meiboscore of grade 0. Note
that the errors are greatly eliminated when applying relaxed
meiboscore conversion criteria. The thresholds near grading
transition limits are marked in blue.
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potentially be applied to other similar image segmen-
tation tasks in the clinical community.
Furthermore, regarding MG atrophy evaluation,
numeric percent atrophy reporting is a better assess-
ment than simple meiboscore grading. It is challeng-
ing to distinguish different meiboscores when the
percent atrophy is near the grading transition limits
(0%, 33%, 66%), because no distinct changes observed
for meibography images in these regions. Forcing a
strict meiboscore near the boundary can lead to
grading inconsistency and variability. When applying
numeric percent atrophy, however, clinicians would
not need to worry about the images with percent
atrophy near these grading transition limits. Addi-
tionally, there are several different grading scales for
gland atrophy.4,5 Conversion between different grad-
ing system is impossible as the percentage information
already got lost. Numeric percent atrophy adopted in
this study overcomes the above-mentioned problems.
In conclusion, a deep learning approach to
automatically evaluate the MG atrophy in meibog-
raphy images has been developed. The system has
high accuracy, repeatability, and low variability, as
well as outperforming human clinicians by a signif-
icant margin. The quantitative outputs (specific
atrophy region and percent atrophy) provide valuable
information of MG atrophy severity of the meibog-
raphy image. In the present work, our deep learning
system could only predict MG atrophy region, but
not individual MG morphology. Future work can
explore how deep learning can automatically analyze
MG morphologic characteristics (e.g., gland number,
width, intensity, and tortuosity), which can be
potentially important for advancing the efficiency of
MGD treatment and management. Capturing human
expert knowledge with data-driven, deep learning
systems is the future of image-based medical diagno-
sis. The possibility of using deep learning methods for
clinical diagnosis in ocular surface diseases is shown.
New surveys can be enabled by automatic and
quantitative evaluations, opening up many exciting
Table 6. Confusion Matrix of LCI and Clinical Meiboscore (%)
Note: Warm colors with small values indicate less agreement.
Figure 9. Examples of failure cases in meiboscore (MS) grading:
human clinicians versus machine algorithm. GT refers to the
ground-truth. Failure cases occur for both clinicians and the
algorithm for the images with percent atrophy near the
meiboscore grading boundaries.
Figure 8. Meiboscore grading performance of the clinical team,
the LCI, and the proposed algorithm. The algorithm outperforms
the LCI meiboscore by 16.0% and clinical team meiboscore by
40.6%.
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opportunities for targeted medical treatment and drug
discoveries.
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